Skip to content
healthcare.dev

Eslicarbazepine Acetate

NDC 67877-588, Eslicarbazepine Acetate, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-588
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211199
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-588 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE800 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
67877-588-306787705883030 TABLET in 1 BOTTLE (67877-588-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/28efe9d2-9d7b-4a7c-8458-098456d06604
  • NADAC price for package 67877058830

    GET /v1/drugs/nadac/67877058830

Use it

Look up 67877-588 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-588 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-588. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.